ICON Basic Shares Outstanding 2010-2025 | ICLR
ICON annual/quarterly basic shares outstanding history and growth rate from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- ICON basic shares outstanding for the quarter ending March 31, 2025 were $0.081B, a 2.45% decline year-over-year.
- ICON basic shares outstanding for the twelve months ending March 31, 2025 were $0.329B, a 0.09% decline year-over-year.
- ICON annual basic shares outstanding for 2024 were $0.082B, a 0.46% increase from 2023.
- ICON annual basic shares outstanding for 2023 were $0.082B, a 0.7% increase from 2022.
- ICON annual basic shares outstanding for 2022 were $0.082B, a 21.49% increase from 2021.
| ICON Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $82 |
| 2023 | $82 |
| 2022 | $82 |
| 2021 | $67 |
| 2020 | $53 |
| 2019 | $54 |
| 2018 | $54 |
| 2017 | $54 |
| 2016 | $55 |
| 2015 | $59 |
| 2014 | $61 |
| 2013 | $61 |
| 2012 | $60 |
| 2011 | $60 |
| 2010 | $60 |
| 2009 | $59 |
| ICON Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $81 |
| 2024-12-31 | $82 |
| 2024-09-30 | $83 |
| 2024-06-30 | $83 |
| 2024-03-31 | $83 |
| 2023-12-31 | $82 |
| 2023-09-30 | $82 |
| 2023-06-30 | $82 |
| 2023-03-31 | $82 |
| 2022-12-31 | $82 |
| 2022-09-30 | $82 |
| 2022-06-30 | $81 |
| 2022-03-31 | $81 |
| 2021-12-31 | $67 |
| 2021-09-30 | $81 |
| 2021-06-30 | $53 |
| 2021-03-31 | $53 |
| 2020-12-31 | $53 |
| 2020-09-30 | $53 |
| 2020-06-30 | $53 |
| 2020-03-31 | $53 |
| 2019-12-31 | $54 |
| 2019-09-30 | $54 |
| 2019-06-30 | $54 |
| 2019-03-31 | $54 |
| 2018-12-31 | $54 |
| 2018-09-30 | $54 |
| 2018-06-30 | $54 |
| 2018-03-31 | $54 |
| 2017-12-31 | $54 |
| 2017-09-30 | $54 |
| 2017-06-30 | $54 |
| 2017-03-31 | $54 |
| 2016-12-31 | $55 |
| 2016-09-30 | $56 |
| 2016-06-30 | $55 |
| 2016-03-31 | $55 |
| 2015-12-31 | $59 |
| 2015-09-30 | $59 |
| 2015-06-30 | $60 |
| 2015-03-31 | $60 |
| 2014-12-31 | $60 |
| 2014-09-30 | $62 |
| 2014-06-30 | $62 |
| 2014-03-31 | $62 |
| 2013-12-31 | $61 |
| 2013-09-30 | $61 |
| 2013-06-30 | $61 |
| 2013-03-31 | $60 |
| 2012-12-31 | $60 |
| 2012-09-30 | $60 |
| 2012-06-30 | $60 |
| 2012-03-31 | $60 |
| 2011-12-31 | $60 |
| 2011-09-30 | $60 |
| 2011-06-30 | $60 |
| 2011-03-31 | $60 |
| 2010-12-31 | $60 |
| 2010-09-30 | $60 |
| 2010-06-30 | $60 |
| 2010-03-31 | $59 |
| 2009-12-31 | $59 |
| 2009-09-30 | $59 |
| 2009-06-30 | $59 |
| 2009-03-31 | $59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.324B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.728B | 26.96 |
| Elevance Health (ELV) | United States | $94.145B | 12.15 |
| CVS Health (CVS) | United States | $81.986B | 10.19 |
| Cencora (COR) | United States | $53.983B | 18.77 |
| Natera (NTRA) | United States | $21.477B | 0.00 |
| DiDi Global (DIDIY) | China | $21.462B | 32.57 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.941B | 13.70 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.036B | 0.00 |
| Revvity (RVTY) | United States | $11.610B | 19.98 |
| Doximity (DOCS) | United States | $11.396B | 59.26 |
| CochLear (CHEOY) | Australia | $11.195B | 0.00 |
| Viatris (VTRS) | United States | $10.516B | 3.61 |
| Medpace Holdings (MEDP) | United States | $9.017B | 23.95 |
| Avantor (AVTR) | United States | $8.859B | 12.87 |
| HealthEquity (HQY) | United States | $8.361B | 41.13 |
| Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.027B | 13.77 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.202B | 24.77 |
| BrightSpring Health Services (BTSG) | United States | $3.894B | 36.05 |
| Sotera Health (SHC) | United States | $3.832B | 21.77 |
| Surgery Partners (SGRY) | United States | $2.982B | 38.77 |
| Alignment Healthcare (ALHC) | United States | $2.952B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 16.01 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 9.04 |
| Premier (PINC) | United States | $2.101B | 14.38 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.683B | 64.83 |
| GoodRx Holdings (GDRX) | United States | $1.669B | 31.07 |
| Teladoc Health (TDOC) | United States | $1.289B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.234B | 9.39 |
| Agilon Health (AGL) | United States | $1.229B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.000B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.911B | 14.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.866B | 8.11 |
| Embecta (EMBC) | United States | $0.725B | 4.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.689B | 13.50 |
| Enhabit (EHAB) | United States | $0.530B | 43.58 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.513B | 13.59 |
| Sonida Senior Living (SNDA) | United States | $0.512B | 0.00 |
| LifeMD (LFMD) | United States | $0.389B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| SBC Medicals (SBC) | United States | $0.359B | 0.00 |
| Beauty Health (SKIN) | United States | $0.220B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.193B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.08 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| ModivCare (MODV) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |